MALESCI, Alberto Carlo Piero
 Distribuzione geografica
Continente #
NA - Nord America 10.165
AS - Asia 3.302
EU - Europa 1.690
SA - Sud America 867
AF - Africa 268
Continente sconosciuto - Info sul continente non disponibili 32
OC - Oceania 16
Totale 16.340
Nazione #
US - Stati Uniti d'America 9.992
SG - Singapore 2.039
BR - Brasile 761
CN - Cina 730
FI - Finlandia 387
IE - Irlanda 248
NG - Nigeria 214
IT - Italia 181
DE - Germania 176
FR - Francia 141
CA - Canada 128
GB - Regno Unito 111
NL - Olanda 99
HK - Hong Kong 97
SE - Svezia 97
TR - Turchia 81
VN - Vietnam 74
IN - India 56
BE - Belgio 38
AR - Argentina 35
MX - Messico 32
RU - Federazione Russa 32
A2 - ???statistics.table.value.countryCode.A2??? 30
IL - Israele 28
BD - Bangladesh 27
ES - Italia 25
IQ - Iraq 25
JP - Giappone 25
PL - Polonia 23
UA - Ucraina 22
CL - Cile 21
MK - Macedonia 20
RO - Romania 18
ZA - Sudafrica 18
CZ - Repubblica Ceca 17
VE - Venezuela 15
AU - Australia 14
ID - Indonesia 13
EC - Ecuador 12
PK - Pakistan 12
IR - Iran 11
KR - Corea 11
GR - Grecia 9
PH - Filippine 9
AE - Emirati Arabi Uniti 8
NO - Norvegia 8
CH - Svizzera 7
CO - Colombia 7
NP - Nepal 7
SA - Arabia Saudita 7
TN - Tunisia 7
DZ - Algeria 6
KE - Kenya 6
MA - Marocco 6
AL - Albania 5
AT - Austria 5
AZ - Azerbaigian 5
KG - Kirghizistan 5
LT - Lituania 5
MD - Moldavia 5
PE - Perù 5
UZ - Uzbekistan 5
AO - Angola 4
EG - Egitto 4
KZ - Kazakistan 4
OM - Oman 4
PY - Paraguay 4
UY - Uruguay 4
BN - Brunei Darussalam 3
BO - Bolivia 3
GE - Georgia 3
HU - Ungheria 3
JO - Giordania 3
PS - Palestinian Territory 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
DK - Danimarca 2
EU - Europa 2
HN - Honduras 2
JM - Giamaica 2
NZ - Nuova Zelanda 2
PA - Panama 2
BH - Bahrain 1
BY - Bielorussia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GA - Gabon 1
GT - Guatemala 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
NI - Nicaragua 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
UG - Uganda 1
Totale 16.340
Città #
Wilmington 1.548
Chandler 1.490
Dallas 822
Singapore 698
San Mateo 577
The Dalles 563
Ann Arbor 505
Shanghai 418
Helsinki 379
Boardman 317
Leawood 275
Ashburn 265
Dublin 246
Lawrence 238
Princeton 238
New York 233
Benin City 214
Beijing 141
Fairfield 141
Paris 135
Woodbridge 132
Columbus 120
Hong Kong 97
Toronto 93
Amsterdam 90
Kocaeli 65
Milan 65
São Paulo 65
Seattle 62
London 57
Council Bluffs 56
Falls Church 51
Los Angeles 51
Phoenix 46
Norwalk 38
Brussels 37
San Diego 37
Ho Chi Minh City 35
Munich 32
Santa Clara 28
Rio de Janeiro 27
Abbiategrasso 23
Monmouth Junction 22
Clearwater 21
Belo Horizonte 20
Brooklyn 20
Houston 20
Tokyo 19
Pune 17
Curitiba 15
Tappahannock 13
Campinas 12
Chicago 12
Hanoi 12
Naples 12
San Francisco 12
Warsaw 12
Baghdad 11
Brno 11
Jakarta 11
Mexico City 11
Redwood City 11
Brasília 10
Falkenstein 10
Frankfurt am Main 10
Seoul 10
Boston 9
Skopje 9
Atlanta 8
Des Moines 8
Johannesburg 8
Sacramento 8
Stockholm 8
Turku 8
Andover 7
Betim 7
Chennai 7
Dhaka 7
Mumbai 7
Redmond 7
Cambridge 6
Campo Grande 6
Contagem 6
Las Vegas 6
Monterrey 6
Montreal 6
Moscow 6
Nairobi 6
Novokuznetsk 6
Orem 6
Porto Alegre 6
Santo André 6
São Gonçalo 6
Winnipeg 6
Baku 5
Bishkek 5
Bitola 5
Chisinau 5
Denver 5
Guangzhou 5
Totale 11.306
Nome #
Biological agents for ulcerative colitis : Hypes and hopes 291
Outcome of Sars-COV-2-related thyrotoxicosis in survivors of Covid-19: a prospective study 182
Endoscopic submucosal dissection of early gastric neoplastic lesions : a western series 160
Activation of the VEGFC/VEGFR3 Pathway Induces Tumor Immune Escape in Colorectal Cancer 131
Bacterial sensor triggering receptor expressed on myeloid cells-2 regulates the mucosal inflammatory response 127
A Prospective Comparison Between Computerized Tomography (CT) and Magnetic Resonance (MR) in Ileo-Colonic Crohn's Disease: A Single-Center Experience. 124
Quantitative evaluation of RASSFIA methylation in the non-lesional, regenerative and neoplastic liver 123
Adalimumab in ulcerative colitis: hypes and hopes 116
Molecular heterogeneity and prognostic implications of synchronous advanced colorectal neoplasia 116
Balanced poropofol sedation in patients undergoing EUS-FNA: a pilot study to assess feasibility and safety 114
Budesonide : teaching an old dog new tricks for inflammatory bowel disease treatment 113
The urokinase plasminogen activator receptor (uPAR) controls macrophage phagocytosis in intestinal inflammation 110
Autonomic nervous system dysregulation in irritable bowel syndrome 108
Serum CA 19-9 in the postsurgical follow-up of patients with pancreatic cancer 104
Balanced propofol sedation administered by nonanesthesiologists : the first Italian experience 103
A Prospective Comparison Between 1.5t Magnetic Resonance and 3t Magnetic Resonance in Ileo-Colonic Crohn's Disease: A Single Center Experience 102
A PROSPECTIVE, SINGLE CENTER STUDY OF ENDOSCOPIC SUBMUCOSAL DISSECTION OF RECTAL LST LESIONS > 3 CM BY USING AN INNOVATIVE CONCEPT OF INJECTING AND CUTTING: THE WATER-JET HYBRID-KNIFE (ESD-H) 102
Absence of tolerance in duodenal ulcer patients treated for 28 days with a bedtime dose of roxatidine or ranitidine 99
Adalimumab is effective in achieving clinical and endoscopic long-term deep remission : a case report 98
Unique role of junctional adhesion molecule-A in maintaining mucosal homeostasis in inflammatory bowel disease 97
Prospective comparison of computed tomography enterography and magnetic resonance enterography for assessment of disease activity and complications in ileocolonic Crohn's disease 97
Crucial role of the protein C pathway in governing microvascular inflammation in inflammatory bowel disease 97
Achalasia with dense eosinophilic infiltrate responds to steroidal therapy 95
Costo sociale annuo della dispepsia funzionale dopo l'eradicazione dell'Helicobacter pylori : risultati di un'indagine in centri di endoscopia digestiva 95
Colitis-associated cancer: the dark side of inflammatory bowel disease 94
Anti-adhesion molecule therapies in inflammatory bowel disease: touch and go 94
Occurrence and significance of tumor - Associated neutrophils in patients with colorectal cancer 93
Tumor-associated macrophages and response to 5-flourouracil adjuvant therapy in stage III colorectal cancer 93
New insights into inflammatory bowel disease pathophysiology: Paving the way for novel therapeutic targets 92
A new metal stent with a controlled-release system for palliation of malignant dysphagia a prospective, multicenter study 92
Narrow-band imaging endoscopy to assess mucosal angiogenesis in inflammatory bowel disease: a pilot study 92
Hereditary or sporadic polyposis syndromes 91
Genetic and epigenetic alterations in primary colorectal cancers and related lymph node and liver metastases 91
Observation of thoracic duct morphology in portal hypertension by endoscopic ultrasound 91
K-ras and p16(INK4A) alterations in sputum of NSCLC patients and in heavy asymptomatic chronic smokers 91
Prognostic value of innate and adaptive immunity in colorectal cancer 91
Colifagina, a novel preparation of 8 lysed bacteria ameliorates experimental colitis 91
Fractionation of immunoreactive cholecystokinin by adsorption to QUSO or talc 90
C(Tr)/C(Cr) ratio in pancreatic disease 89
Determination of CA 19-9 antigen in serum and pancreatic juice for differential diagnosis of pancreatic adenocarcinoma from chronic pancreatitis. 89
Abdominal cocoon or idiopathic encapsulating peritoneal sclerosis : magnetic resonance imaging 89
Adalimumab in Crohn's disease : tips and tricks after 5 years of clinical experience 89
Balanced Propofol Sedation (BPS) Administered by Non-Anesthesiologists vs Midazolam Alone for Endoscopic Procedure in Patients With IBD: A Single Center Open-Label Trial 88
Internet use among inflammatory bowel disease patients: an Italian multicenter survey 87
New Drug Delivery Systems in Inflammatory Bowel Disease: MMX (TM) and Tailored Delivery to the Gut 87
VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis 85
Endoscopic submucosal dissection in patients with early esophageal squamous cell carcinoma : results from a prospective Western series 83
mTOR-Dependent Stimulation of IL20RA Orchestrates Immune Cell Trafficking through Lymphatic Endothelium in Patients with Crohn's Disease 83
A case of esophageal squamous cell intraepithelial neoplasia with positivity for type 16 human papillomavirus successfully treated with radiofrequency ablation 83
COVID-19 Digestive System Involvement and Clinical Outcomes in a Large Academic Hospital in Milan, Italy 83
Endoscopic flexible treatment of Zenker's diverticulum: a modification of the needle-knife technique 82
Gastric histology and function tests in Italian patients with dermatitis herpetiformis 82
Effect of Immunosuppression on Immune Response to Pneumococcal Vaccine in Inflammatory Bowel Disease: A Prospective Study 82
Efficacy and safety of biodegradable stents for refractory benign esophageal strictures: the BEST (Biodegradable Esophageal Stent) study 81
Endoscopic mucosal resection for early colorectal neoplasia: pathologic basis, procedures, and outcomes. 81
Tipizzazione linfocitaria nelle epatopatie croniche 81
Italian consensus guidelines for chronic pancreatitis 81
SPINK1 and PRSS1 mutations in benign pancreatic hyperenzymemia 81
WallFlex colonic stent placement for management of malignant colonic obstruction : a prospective study at two centers 81
The chemokine receptor CX3CR1 is involved in the neural tropism and malignant behavior of pancreatic ductal adenocarcinoma 81
Emerging biologics in the treatment of inflammatory bowel disease : what is around the corner? 80
Low density of CD3+ cells at the invasion front and increased risk of liver metastases development in microsatellite-stable colorectal cancer patients 80
Presence of twist1-positive neoplastic cells in the stroma of chromosome-unstable colorectal tumors 80
Stenting of the proximal colon in patients with malignant large bowel obstruction: techniques and outcomes 79
No effect of long-term treatment with pancreatic extract on recurrent abdominal pain in patients with chronic pancreatitis 79
Microsatellite instability and therapeutic consequences in colorectal cancer 79
Bowel damage as assessed by the Lémann Index is reversible on anti-TNF therapy for Crohn's disease 79
Tumour-associated macrophages as treatment targets in oncology 78
Serum pepsinogen I elevation in cigarette smokers 78
Impact of Tumour Necrosis Factor Antagonists on Avoiding Surgery in Stricturing Crohn's Disease: A Tertiary Center Real-Life Experience 78
Impact of Medications on Radiologic Disease Activity and Bowel Damage in Crohn's Disease: A Prospective Longitudinal MRI Study 78
High efficacy of endoscopic submucosal dissection for rectal laterally spreading tumors larger than 3 cm 77
The bacterial sensor Triggering Receptor Expressed on Myeloid cells 2 (TREM-2) is a crucial pathogenic mediator in inflammatory bowel disease (IBD) 77
Critical role of the CD40-CD40-ligand pathway in regulating mucosal inflammation-driven angiogenesis in inflammatory bowel disease 77
Nissen fundoplication after failure of endoluminal fundoplication: short term results 76
Frameshift mutations of human gastrin receptor gene (hGARE) in gastrointestinal cancers with microsatellite instability 76
Cholecystokinin-converting enzymes in brain 76
Evaluation of peripheral and CNS biochemical changes in models of acute and chronic experimental hepatic insufficiency in the rat 76
Purification and assay of secretory lithostathine in human pancreatic juice by fast protein liquid chromatography 76
Effect of Oral Administration of Methylene Blue MMx (R) Tablets on Double-Stranded DNA Damage Assessed by gamma H2AX Analysis of Colon Biopsy Samples - A Single Center, Open Label, Safety, Phase II Study 76
CA 19-9 in serum and pancreatic juice : its role in the differential diagnosis of resectable pancreatic cancer from chronic pancreatitis 76
Combined low densities of FoxP3+ and CD3+ tumor-infiltrating lymphocytes identify stage II colorectal cancer at high risk of progression 76
Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices : a prospective multicenter study 76
MFSD2A Promotes Endothelial Generation of Inflammation-resolving Lipid Mediators and Reduces Colitis in Mice 76
CA 19-9 and diagnosis of pancreatic carcinoma 75
Effect of gastric acid secretion on intestinal phosphate and calcium absorption in normal subjects 75
Contrast-enhancement at magnetic resonance enterography does not differentiate between fibrosis and inflammation in Crohn's disease: a prospective cohort study 75
Effects of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease : a prospective study 75
Partial regression of Barrett's esophagus by long-term therapy with high-dose omeprazole 74
Once-Daily Bedtime Dose of Roxatidine and Ranitidine in Acute Duodenal Ulcer: A Combined Assessment of Acid Inhibitory Activity and Healing Rate 74
Circadian acidity pattern in gastric ulcers at different sites 74
Inflammation and coagulation in inflammatory bowel disease: The clot thickens 73
Pancreatic cancer or chronic pancreatitis? An answer from PET/MRI image fusion 73
Imaging Modalities for Perianal Crohn's Disease 73
Occurrence of tertiary lymphoid tissue is associated with T-cell infiltration and predicts better prognosis in early-stage colorectal cancers 73
Enhanced platelet adhesion induces angiogenesis in intestinal inflammation and inflammatory bowel disease microvasculature 73
Pancreatic polypeptide response to food and cerulein in patients with total gastrectomy 72
Review article: anti TNF-alpha induced psoriasis in patients with inflammatory bowel disease 72
Review article: anti-fibrotic agents for the treatment of Crohn's disease - lessons learnt from other diseases 71
Comparison of 24-h control of gastric acidity by three different dosages of pantoprazole in patients with duodenal ulcer 70
Totale 9.069
Categoria #
all - tutte 125.639
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 125.639


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.836 0 0 0 0 0 901 398 186 512 362 19 458
2021/20221.916 193 30 53 321 40 38 58 210 142 265 479 87
2022/20233.791 540 163 345 458 343 341 3 315 723 290 235 35
2023/20242.019 194 229 370 136 58 277 109 101 51 44 136 314
2024/20253.044 130 111 35 131 129 392 170 380 353 620 339 254
2025/20263.086 1.044 422 823 499 250 48 0 0 0 0 0 0
Totale 16.856